Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)

NCT00053703 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Risperidone
DRUG: Olanzapine (enrollment closed in this treatment)
DRUG: Molindone

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]